• IMA sites
  • IMAJ services
  • IMA journals
  • Follow us
  • Alternate Text Alternate Text
עמוד בית
Thu, 10.07.25

REVIEWS

IMAJ | volume 27

Journal 6, June 2025
pages: 398-404

Guidelines for the Treatment of Infantile Hemangiomas: A Position Paper from the Israeli Association of Dermatology and Venereology

1 Pediatric Dermatology Service, Shaare Zedek Medical Center, affiliated with Hadassah–Hebrew University School of Medicine, Jerusalem, Israel 2 Pediatric Dermatology Service, Wolfson Medical Center, Holon, Israel 3 Pediatric Dermatology Unit, Schneider Children's Medical Center, Petah Tikva, Israel 4 Department of Dermatology, Pediatric Dermatology Service, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel 5 Department of Dermatology, Pediatric Dermatology Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 6 Department of Pediatrics, Carmel Medical Center, Haifa, Israel 7 Department of Dermatology, Rambam Health Care Campus, Haifa, Israel 8 Department of Dermatology, Emek Medical Center, Afula, Israel 9 Pediatric Dermatology Service, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel 10 Department of Dermatology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel 11 Adelson School of Medicine, Ariel University, Ariel, Israel 12 Assuta Medical Center, Tel Aviv, Israel 13 Department of Dermatology, Pediatric Dermatology Unit, Sheba Medical Center, Tel Hashomer, Israel 14 Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel 15 Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, Haifa, Israel 16 Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel

Summary

Infantile hemangioma (IH) is the most common benign vascular tumor in infancy. Recent advances, particularly in beta-blocker therapy, have significantly improved the management of IHs. Early identification and treatment of IH may help reduce morbidity and associated complications. In this review, experts in pediatric dermatology in Israel who have experience in treating IH formulated national guidelines for the diagnosis and treatment of IHs, providing evidence-based recommendations for selecting appropriate therapeutic approaches. These Israeli national guidelines provide a structured approach to the diagnosis and treatment of IH, emphasizing early referral, appropriate treatment selection, and careful monitoring. The guidelines serve as a critical resource for pediatricians and dermatologists, ensuring optimal patient outcomes while minimizing complications.

Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter.
The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.
© All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy

2 Twin Towers, 35 Jabotinsky, POB 4292, Ramat Gan 5251108 Israel